| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.55▼ | 6.55▼ | 6.55▼ | 6.55▼ | 6.51▼ |
| MA10 | 6.54▼ | 6.52▼ | 6.52▼ | 6.51▼ | 6.39▼ |
| MA20 | 6.45▲ | 6.42▲ | 6.42▲ | 6.51▼ | 6.05▲ |
| MA50 | 6.29▲ | 6.26▲ | 6.28▲ | 6.42▼ | 6.11▲ |
| MA100 | 6.29▲ | 6.33▲ | 6.29▲ | 6.07▲ | 5.27▲ |
| MA200 | 6.25▲ | 5.97▲ | 6.02▲ | 6.24▲ | 5.70▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.000▲ | 0.001▲ | -0.011▼ | 0.046▲ |
| RSI | 52.843▲ | 53.653▲ | 53.411▲ | 47.072▼ | 52.908▲ |
| STOCH | 60.708 | 65.044 | 65.271 | 74.285 | 58.836 |
| WILL %R | -66.000 | -66.000 | -50.769 | -63.455 | -45.732 |
| CCI | -16.553 | -6.564 | 0.885 | -25.463 | 46.549 |
|
Friday, March 06, 2026 05:05 AM
ImmuCell Corporation (NASDAQ:ICCC) Q4 2025 Earnings Call Transcript March 5, 2026 Operator: Good morning, and welcome to the ImmuCell Corporation Conference Call to discuss Unaudited Fourth Quarter ...
|
|
Thursday, March 05, 2026 11:07 AM
The CEO highlighted the challenge of measuring revenue recurrence due to previous supply constraints and customer churn calculations.
|
|
Thursday, March 05, 2026 02:27 AM
ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), an animal health company that develops, manufactures and markets products that improve ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/03/26 | 6.61 | 6.6999 | 6.33 | 6.37 | 17,283 |
| 12/03/26 | 6.55 | 6.63 | 6.55 | 6.63 | 1,106 |
| 11/03/26 | 6.63 | 6.665 | 6.62 | 6.65 | 9,373 |
| 10/03/26 | 6.39 | 6.65 | 6.39 | 6.63 | 13,639 |
| 09/03/26 | 6.42 | 6.49 | 6.2601 | 6.48 | 12,829 |
| 06/03/26 | 6.30 | 6.61 | 6.2598 | 6.60 | 15,303 |
| 05/03/26 | 6.42 | 6.42 | 6.22 | 6.35 | 38,238 |
| 04/03/26 | 6.31 | 6.46 | 6.20 | 6.46 | 12,029 |
| 03/03/26 | 6.50 | 6.55 | 6.18 | 6.40 | 16,534 |
| 02/03/26 | 6.6908 | 6.6908 | 6.50 | 6.54 | 3,152 |
|
|
||||
|
|
||||
|
|